A slew of National Institutes of Health grant terminations in the spring left affected Northwestern researchers with few ...
The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...
Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...
People with type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...
After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...
Verywell Health on MSN
New Menopause Drug Lynkuet Could Ease Hot Flashes and Night Sweats
The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.
A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections ...
To get the dose right, it is crucial that the radiation doses associated with any medical practice, whether diagnosis or treatment, are accurately known. A dose measurement should be traceable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results